Author(s):
Gandi Anusha, Shaik Nargiz, Allu Sireesha, Kona Poojitha, K.Varaprasada Rao, Y. Srinivasa Rao
Email(s):
gandianusha11@gmail.com
DOI:
10.52711/0974-360X.2024.00797 
Address:
Gandi Anusha*, Shaik Nargiz, Allu Sireesha, Kona Poojitha, K.Varaprasada Rao, Y. Srinivasa Rao
Department of Pharmaceutical Analysis, Vignan Institute of Pharmaceutical Technology,
Besides VSEZ, Kapujaggraju Peta, Duvvada, Visakhapatnam, Andhra Pradesh 530049, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 11,
Year - 2024
ABSTRACT:
A type of antiviral medicine called molnupiravir is used to treat viral infections. Using green solvent as methanol, a precise and affordable UV spectrophotometric technique has been created. It was demonstrated how to determine the Molnupiravir concentration in pharmaceutical dose formulations and bulk samples at a preset ? max of 236nm. Beer limitations were found to have a regression equation of (y=0.0457x-0.0031) and an excellent correlation coefficient (R2=0.999). The quantity of molnupiravir in marketed brands from local markets was determined using this method successfully, and the results were in excellent agreement with the claim on the label. According to the standards of the International Conference on Harmonisation (ICH), the method's linearity, accuracy, precision, robustness, and ruggedness were all validated. The obtained outcomes demonstrated the method's suitability for regular analysis of Molnupiravir in bulk as well as formulation.
Cite this article:
Gandi Anusha, Shaik Nargiz, Allu Sireesha, Kona Poojitha, K.Varaprasada Rao, Y. Srinivasa Rao. Green Solvent-Based UV Spectrophotometric Technique for Quantifying Molnupiravir in Bulk and Pharmaceutical Formulation. Research Journal of Pharmacy and Technology. 2024; 17(11):5210-4. doi: 10.52711/0974-360X.2024.00797
Cite(Electronic):
Gandi Anusha, Shaik Nargiz, Allu Sireesha, Kona Poojitha, K.Varaprasada Rao, Y. Srinivasa Rao. Green Solvent-Based UV Spectrophotometric Technique for Quantifying Molnupiravir in Bulk and Pharmaceutical Formulation. Research Journal of Pharmacy and Technology. 2024; 17(11):5210-4. doi: 10.52711/0974-360X.2024.00797 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-11-5
REFERENCES:
1. Toots M, Yoon JJ, Cox RM, Hart M, Sticher ZM, Makhsous N, Plesker R, Barrena AH, Reddy PG, Mitchell DG, Shean RC. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Science Translational Medicine. 2019; Oct 23; 11(515). DOI: 10.1126/scitranslmed.aax586.
2. 67209 - Food and Drug Administration (FDA). Fact sheet for healthcare providers: emergency use authorization for molnupiravir. Retrieved February 1, 2023 Available on the World Wide Web.
3. Annadi AM, El Zahar NM, Abdel-Sattar NE, Mohamed EH, Mahmoud SA, Attia MS. Development and validation of molnupiravir assessment in bulk powder and pharmaceutical formulation by the RP-HPLC-UV method. RSC Advances. 2022; 12(53): 34512-9. DOI: 10.1039/D2RA05066H
4. Reçber T, Timur SS, Kablan SE, Yalçın F, Karabulut TC, Gürsoy RN, Eroglu H, Kır S, Nemutlu E. A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies. Journal of Pharmaceutical and Biomedical Analysis. 2022; May 30; 214: 114693. https://doi.org/10.1016/j.jpba.2022.114693
5. Abdelazim AH, Abourehab MA, Abd Elhalim LM, Almrasy AA, Ramzy S. Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2023; Jan 15; 285: 121911. https://doi.org/10.1016/j.saa.2022.121911
6. Bindu M, Gandla K, Vemireddy S, Samuel S, Praharsha Y. A validated stability indicating RP-HPLC method for the determination of molnupiravir in pharmaceutical dosage form. World Journal of Advanced Research and Reviews. 2022; 15(1): 580-90. DOI: 10.30574/wjarr.2022.15.1.0720.
7. Amara A, Penchala SD, Else L, Hale C, FitzGerald R, Walker L, Lyons R, Fletcher T, Khoo S. The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva. Journal of Pharmaceutical and Biomedical Analysis. 2021 Nov 30; 206: 114356. https://doi.org/10.1016/j.jpba.2021.114356
8. Mohamed AR, Abolmagd E, Nour IM, Badrawy M, Hasan MA. Earth-friendly-assessed silver-nanoparticles spectrophotometric method for rapid and sensitive analysis of Molnupiravir, an FDA-approved candidate for COVID-19: application on pharmaceutical formulation and dissolution test. BMC Chemistry. 2023; Mar 10; 17(1): 13.10.1186/s13065-023-00933-2
9. Saraya RE, Deeb SE, Salman BI, Ibrahim AE. Highly sensitive high‐performance thin‐layer chromatography method for the simultaneous determination of molnupiravir, favipiravir, and ritonavir in pure forms and Pharmaceutical formulations. Journal of Separation Science. 2022; Jul; 45(14): 2582-90. https://doi.org/10.1002/jssc.202200178
10. Reddy KT, Haque MA. Develop and validate a highly sensitive method for the estimation of Molnupiravir in rat plasma by high-performance liquid chromatography-tandem mass spectroscopy and its application to pharmacokinetic studies. Journal of Pharmaceutical Negative Results. 2022; Sep 21: 28-34. DOI: https://doi.org/10.47750/pnr.2022.13.S01.04
11. Mahmoud NE, Youssef AO, Attia MS. Spectrophotometric Method Development and Validation for the Determination of Molnupiravir in Bulk Powder and Pharmaceutical Formulation. Egyptian Journal of Chemistry. 2023 Oct 1;66(10):423-9.DOI: 10.21608/ejchem.2023.135533.5970
12. Kumar GR, Babu BS, Rao RR, Vardhan VM, Abbaraju VD. Method development and validation of a specific stability indicating RP-HPLC method for molnupiravir API. Journal of Pharmaceutical Research International. 2021 Dec 27;33(60B):3026-https://doi.org/10.9734/jpri/2021/v33i60B34973
13. Sravanthi G, Gandla KS, Repudi L. New analytical method development and validation for estimation of molnupiravir in bulk and tablet dosage form by RP-HPLC method. Cellular, Molecular and Biomedical Reports. 2023 Sep 1;3(3):130-6.https://doi.org/10.55705/cmbr.2023.375093.1087.
14. Camlik G, Beyazaslan F, Kara E, Ulker D, Albayrak I, Degim IT. A validated high-pressure liquid chromatography (HPLC) method for Molnupiravir. Medical Research Archives. 2022 Sep 20;10(9).DOI: https://doi.org/10.18103/mra.v10i9.3127.
15. Suresh CV, Mamatha T, Santhosh Illendula DK. An analytical new RP-HPLC method for the quantitative determination of molnupiravir in bulk and tablet dosage form. International Journal of Advanced Research in Medical & Pharmaceutical Sciences. 2023;8(1).
16. Rele Rajan V., Tiwatane Prathamesh P. Determination of Molnupiravir by Extractive Colorimetric Method from Pharmaceutical Dosage Form. Asian Journal of Research in Chemistry. 2022; 15(4): 256-8.
17. Rele Rajan V., Tiwatane Prathamesh P.. A Validated Potentiometric Titration Method for Quantitative Determination of Molnupiravir from Pharmaceutical Preparation. Asian Journal of Research in Chemistry. 2022; 15(6):439-2.
18. Rele Rajan V., Tiwatane Prathamesh P. Simple Extractive Spectrophotometric Method for Determination of Molnupiravir from Pharmaceutical Formulation. Asian Journal of Research in Chemistry. 2023; 16(2):155-8.
19. Validation of Compendial Procedures 1225>, the United States Pharmacopeia, 32th Rev., and the National Formulary, 27th Rev., Rockville, MD: The United States Pharmacopeial Convention Inc. 2009; I: 735.
20. Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH Harmonized Tripartite guidelines, International Conference on Harmonization of Technical Requirements for Registration Of Pharmaceuticals For Human Use. 2005; 10.
21. Guideline on bioanalytical method validation, European Medicines Agency, London, UK, 2011; I: 8.
22. Validation of Analytical Procedures SC III F, British Pharmacopeia, British Pharmacopeia Commission. 2013.
23. Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH Harmonized Tripartite guidelines, International Conference on Harmonization of Technical Requirements for Registration Of Pharmaceuticals For Human Use. 2005; 5.
24. Validation of Compendial Procedures 1225>, The United States Pharmacopeia, 32th Rev., and The National Formulary, 27th Rev., Rockville, MD: The United States Pharmacopeial Convention Inc. 2009; I: 737.
25. Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH Harmonized Tripartite guidelines, International Conference on Harmonization of Technical Requirements for Registration Of Pharmaceuticals For Human Use. 2005; 9.
26. Validation of Compendial Procedures 1225>, The United States Pharmacopeia, 32th Rev., and The National Formulary, 27th Rev., Rockville, MD: The United States Pharmacopeial Convention Inc. 2009; I: 738.
27. Sahoo CK, Sudhakar M, Ramana DV, Satyanarayana K, Panda KC. Validation of analytical procedures-A review. Asian Journal of Pharmaceutical Analysis. 2018; 8(2): 109-16.
28. Shingote V, Mankar SD, Dighe SB. A review article on analytical methods development and validation. Research Journal of Science and Technology. 2022; 14(1): 77-83.